Beta Bionics, Inc. (BBNX) PT Raised to $19 at Goldman Sachs
Tweet
Share
E-mailGet Alerts BBNX Hot Sheet
Price: $18.08 --0%
Rating Summary:
8 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
8 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Goldman Sachs analyst David Roman raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $19.00 (from $17.00) while maintaining a Buy rating.
You May Also Be Interested In
- Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
- SanDisk (SNDK) PT Raised to $1,600 at RBC Capital
- Cellebrite (CLBT) PT Lowered to $16 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
